Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
EuroEyes International Eye Clinic Limited ( (HK:1846) ) has issued an announcement.
EuroEyes International Eye Clinic Limited has scheduled a board meeting for 31 March 2026 to review and approve the group’s annual results for the year ended 31 December 2025 and to approve their release. The board will also consider whether to recommend a final dividend, a decision that could directly affect shareholder returns and signal management’s confidence in the company’s financial performance and outlook.
The announcement also confirms the current composition of the board, which includes a mix of executive and independent non-executive directors, underscoring the company’s adherence to corporate governance norms. This structure, with independent oversight, may provide investors with additional assurance as the company prepares to disclose its annual financial results and any potential dividend proposal.
The most recent analyst rating on (HK:1846) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on EuroEyes International Eye Clinic Limited stock, see the HK:1846 Stock Forecast page.
More about EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited is an eye-care services provider specializing in ophthalmic treatments and vision correction procedures. Listed on the Hong Kong Stock Exchange, the company operates through a network of clinics and focuses on serving patients seeking surgical solutions for vision problems in its key markets.
Average Trading Volume: 119,678
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$924.1M
See more data about 1846 stock on TipRanks’ Stock Analysis page.